Israeli IceCure Expands Cancer Treatment Technology in Netherlands
Israeli firm IceCure Medical partners with Scovas Medical for exclusive distribution of its ProSense cryoablation cancer treatment in the Netherlands.
Israeli firm IceCure Medical partners with Scovas Medical for exclusive distribution of its ProSense cryoablation cancer treatment in the Netherlands.
IceCure Medical's tumor-freezing ProSense technology is gaining commercial traction in Brazil for breast, lung, kidney, and musculoskeletal tumors.
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".
Israeli MedTech Firm IceCure gains Swiss approval for revolutionary cryoablation cancer therapy, expanding global reach with innovative treatment options.